BSE Live
Jan 21, 16:01Prev. Close
1416.90
Open Price
1408.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 21, 15:55Prev. Close
1410.30
Open Price
1395.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1414.70 (1)
| Key Financial Ratios of Hester Biosciences (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 11.62 | 9.12 | 13.56 | 9.92 | 11.99 | |
| Diluted EPS (Rs.) | 11.62 | 9.12 | 13.56 | 9.92 | 11.99 | |
| Cash EPS (Rs.) | 19.78 | 16.53 | 20.66 | 10.77 | 12.94 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 78.72 | 70.59 | 64.47 | 53.84 | 36.81 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 78.72 | 70.59 | 64.47 | 53.84 | 36.81 | |
| Dividend / Share(Rs.) | 3.00 | 2.50 | 2.50 | 2.00 | 1.50 | |
| Revenue from Operations/Share (Rs.) | 72.30 | 58.10 | 62.86 | 42.05 | 54.31 | |
| PBDIT/Share (Rs.) | 30.63 | 28.21 | 32.90 | 17.28 | 23.85 | |
| PBIT/Share (Rs.) | 22.48 | 20.81 | 25.81 | 16.43 | 22.90 | |
| PBT/Share (Rs.) | 18.49 | 15.70 | 21.01 | 15.29 | 22.52 | |
| Net Profit/Share (Rs.) | 11.62 | 9.12 | 13.56 | 9.92 | 11.99 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 42.36 | 48.55 | 52.34 | 41.10 | 43.92 | |
| PBIT Margin (%) | 31.09 | 35.81 | 41.05 | 39.08 | 42.16 | |
| PBT Margin (%) | 25.57 | 27.03 | 33.42 | 36.35 | 41.47 | |
| Net Profit Margin (%) | 16.07 | 15.70 | 21.57 | 23.59 | 22.07 | |
| Return on Networth / Equity (%) | 14.76 | 12.92 | 21.03 | 18.43 | 32.56 | |
| Return on Capital Employed (%) | 11.63 | 9.43 | 14.31 | 12.89 | 29.71 | |
| Return on Assets (%) | 7.44 | 6.13 | 9.98 | 7.86 | 19.78 | |
| Total Debt/Equity (X) | 0.49 | 0.51 | 0.60 | 0.80 | 0.12 | |
| Asset Turnover Ratio (%) | 46.34 | 39.08 | 46.26 | 33.31 | 89.63 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.41 | 1.36 | 1.39 | 1.18 | 2.05 | |
| Quick Ratio (X) | 0.83 | 0.92 | 1.06 | 0.98 | 1.69 | |
| Inventory Turnover Ratio (X) | 2.21 | 2.58 | 4.66 | 4.37 | 7.33 | |
| Dividend Payout Ratio (NP) (%) | 25.81 | 27.40 | 18.43 | 20.15 | 12.51 | |
| Dividend Payout Ratio (CP) (%) | 15.16 | 15.12 | 12.10 | 18.56 | 11.59 | |
| Earnings Retention Ratio (%) | 74.19 | 72.60 | 81.57 | 79.85 | 87.49 | |
| Cash Earnings Retention Ratio (%) | 84.84 | 84.88 | 87.90 | 81.44 | 88.41 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 87.46 | 55.75 | 81.00 | 54.15 | 39.01 | |
| EV/Net Operating Revenue (X) | 2.33 | 1.85 | 2.48 | 2.48 | 1.94 | |
| EV/EBITDA (X) | 5.50 | 3.81 | 4.74 | 6.04 | 4.41 | |
| MarketCap/Net Operating Revenue (X) | 1.82 | 1.25 | 1.89 | 1.77 | 1.86 | |
| Retention Ratios (%) | 74.18 | 72.59 | 81.56 | 79.84 | 87.48 | |
| Price/BV (X) | 1.67 | 1.03 | 1.84 | 1.38 | 2.75 | |
| Price/Net Operating Revenue | 1.82 | 1.25 | 1.89 | 1.77 | 1.86 | |
| Earnings Yield | 0.09 | 0.13 | 0.11 | 0.13 | 0.12 |
19.11.2025
Hester Bio Consolidated September 2025 Net Sales at Rs 70.97 crore, down 15.2% Y-o-Y
18.11.2025
Hester Bio Standalone September 2025 Net Sales at Rs 64.58 crore, down 12.14% Y-o-Y
01.08.2025
Hester Bio Standalone June 2025 Net Sales at Rs 63.49 crore, down 13.58% Y-o-Y
09.05.2025
Hester Bio Standalone March 2025 Net Sales at Rs 76.67 crore, up 5.21% Y-o-Y
19.11.2025
Hester Bio Consolidated September 2025 Net Sales at Rs 70.97 crore, down 15.2% Y-o-Y
18.11.2025
Hester Bio Standalone September 2025 Net Sales at Rs 64.58 crore, down 12.14% Y-o-Y
01.08.2025
Hester Bio Standalone June 2025 Net Sales at Rs 63.49 crore, down 13.58% Y-o-Y
09.05.2025
Hester Bio Standalone March 2025 Net Sales at Rs 76.67 crore, up 5.21% Y-o-Y